Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias

British Journal of Haematology

Volumn 99, Issue 4, 1997, Pages 858-865

  Kamihira, Shimeru ^a   Yamada, Yasuaki ^a   Hirakata, Yoichi ^a   Tsuruda, Kazuto ^a   Sugahara, Kazuyuki ^a   Tomonaga, Masao ^a   Maeda, Takahiro ^a   Tsukasaki, Kunihiro ^a   Atogami, Sunao ^a   Kobayashi, Nobuyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Apoptosis; ATL; Fas APO 1; Flow cytometry; Oncogenesis

Indexed keywords

FAS ANTIGEN; LACTATE DEHYDROGENASE; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CARCINOGENESIS; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T CELL LEUKEMIA;

EID: 6844265583     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4963301.x     Document Type: Article

References (35)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1989) Proposals for the classification of chronic (mature) B and T lympiund leukaemias. Journal of Clinical Pathology, 42, 567-584.
2. Brisco, M.J., Tan, L.W., Orsborn, A.M. & Morley, A.A. (1990) Development of a highly sensitive away, based on the polymerase chain reaction, for rare B-lymphocyte clones, in a polyclonal population. British Journal of Haematology, 75, 163-167.
3. Cheng, J., Zhout, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J. & Mountz, J.P. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Pas molecule. Science, 263, 1759-1762.
4. Debatin, K.M., Goldman, C.K., Bamford, R., Waldmann, T.A. & Krammer, P.H. (1990) Monoclonal-antibody-mediated apoptosis in adult T cell leukaemia. Lancet, 335, 497-500.
5. Debatin, K.M., Goldman, C.K., Waldmann, T.A. & Krammer, P.H. (1993) APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood, 81, 2972-2977.
6. Debatin, K.M., Suss, D. & Krammer, P.H. (1994) Differential expression of APO-1 on human thymocytes: implications for negative selection? European Journal of Immunology, 24, 753-758.
7. Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P.M. & Runkel, L. (1995) Development of the CD95(APO-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine, 182, 1223-1230.
8. Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E.A., Longthorne, V.L., Culhane, A.C. & Williams, G.T. (1996) Apoptosis: molecular regulation of cell death. European Journal of Biochemistry, 236, 1-26.
9. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Saimeshima, M., Hase, A., Seto, Y. & Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
10. Kamihira, S., Sohda, H., Atogami, S., Toriya, Y., Yamada, K., Tsukasaki, S., Momita, S., Ikeda, S. & Kusano, M. (1992) Phenotypic diversity and prognosis of adult T-cell leukemia. Leukemia Research, 16, 435-441.
11. Kohno, T., Yamada, Y., Hatta, T., Mori, H., Yamamura, M., Tomonaga, M., Urata, Y., Goto, S. & Kondo, T. (1996) Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T-cell leukemia. Journal of Immunology, 156, 4722-4728.
12. Komurian, F., Pellequin, F. & de The, G. (1991) In vivo genomic variability of human T-cell leukemia virus type-1 depends more upon geography than upon pathologies. Journal of Virology, 65, 3770-3778.
13. Kotani, T., Aratake, Y., Kondo, S., Tamura, K. & Ohotaki, S. (1994) Expression of functional Fas antigen on adult T-cell leukemia. Leukemia Research, 18, 305-310.
14. Knipping, E., Debatin, K.M., Stricker, K., Heilig, B., Eder, A. & Krammer, P.H. (1995) Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood, 85, 1562-1569.
15. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, J. & Debatin, K.M. (1994) Regulation of apoptosis in the immune system. Current Opinion in Immunology, 6, 279-289.
16. Le Deist, F., Emile, J.F., Rieux-Laucat, F., Benkerrou, M., Robert, I., Brousse, N. & Fischer, A. (1996) Clinical, immunological, and pathological consequences of Fas-deticient conditions. Lancet, 348, 719-723.
17. Leithauser, F., Dhein, J., Mechtersheimer, G., Kretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K.M., Krammer, P.M. & Moller, P. (1993) Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily, in normal and neoplastic cells. Laboratory Investigation, 69, 415-429.
18. + human bone marrow cells is induced by interferon-r and tumor necrosis factor-alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
19. Matsuyama, T., Hamamoto, Y., Soma, G., Mizuno, D., Yamamoto, N. & Kobayashi, N. (1989) Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication. Journal of Virology, 63, 2504-2509.
20. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J. & Trayth, B.C. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. Journal of Biological Chemistry, 267, 10709-10715.
21. Panayiotidis, P., Ganeshaguru, K., Foroni, L. & Hoffbrand, A.V. (1995) Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia, 9, 1227-1232.
22. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. & Gallo, R.C. (1980) Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 77, 7415-7419.
23. Poncelet, P. & Carayon, P. (1985) Cytofluorometric quantification of cell surface antigen by indirect immunofluorescence using monoclonal antibodies. Journal of Immunological Methods, 85, 65-745.
24. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A.C., Debatin, K.M., Fischer, A. & De Villartay, J.P. (1995) Mutations in Fas as associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
25. Selleri, C., Sato, T., Vecchio, L.D., Luciano, L., Barrett, A.J., Rotoli, B., Young, N.S. & Maciejewski, J.P. (1997) Involvement of Fasmediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood, 89, 957-964.
26. Shimoyama, M., and members of the lymphoma study group (1984-87) (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. British Journal of Haematology, 79, 428-437.
27. Strand, S., Hofmann, W.J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W. & Galle, P.R. (1996) Lymphocyte apoptosis induced by CD95(APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nature Medicine, 2, 1361-1366.
28. Suda, T., Takahashi, T., Golstein, P. & Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
29. Sugahara, K., Yamada, Y., Hiragata, Y., Matsuo, Y., Tsuruda, K., Tomonaga, M., Maeda, T., Atogami, S., Tsukasaki, K. & Kamihira, S. (1997) Soluble and membrane isoforms of Fas/CD95 in fresh adult T-cell leukemia (ATL) cells and ATL-cell lines. International Journal of Cancer, 72, 1-5.
30. Tachibana, O., Nakazawa, H., Lampe, J., Watanabe, K., Kleihues, P. & Ohogaki, H. (1995) Expression of Fas/Apo-1 during the progression of astrocytomas. Cancer Research, 55, 5528-5530.
31. Waldmann, T.A. (1989) Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma. Journal of the National Cancer Institute, 81, 914-923.
32. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkin, N.A. & Nagata, S. (1992) Lymphoproliferation disorders in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314-317.
33. Watson, M.L., Rao, J.K., Gilkeson, G.S., Ruiz, P., Eicher, E.M., Pisetsky, D.S., Matsuzawa, A., Rochelle, J.M. & Seldin, M.F. (1992) Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. Journal of Experimental Medicine, 179, 1645-1656.
34. Yamada, T., Yamaoka, S., Goto, T., Nakai, M., Tsujimoto, Y. & Hatanaka, M. (1994) The human T-cell leukemia virus type-1 Tax protein induces apoptosis which is blocked by the bcl-2 protein. Journal of Virology, 68, 3374-3379.
35. Yonehara, S., Ishii, A. & Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigens co-downregulated with the receptor of tumor necrosis factor. Journal of Experimental Medicine, 169, 1747-1756.